All News
Filter News
Found 808,690 articles
-
Noise Device Tackles Youth Yobs
12/13/2006
-
Salix Pharmaceuticals, Ltd. Release: OSMOPREP™ Tablets Granted MHRA Marketing Approval
12/13/2006
-
Barr Laboratories Confirms Generic Thalomid(R) Capsule Application
12/13/2006
-
FDA Accepts New Drug Application For SANCTURA XR(TM) Submitted By Indevus Pharmaceuticals, Inc.
12/13/2006
-
Celgene Notified Of ANDA Filing For Thalidomide
12/13/2006
-
Pain Therapeutics Initiates Phase III Study With Oxytrex(TM)
12/13/2006
-
Marshall Edwards, Inc. Announces Initial Trial Sites, Principle Investigator For Phase III OVATURE Trial For Phenoxodiol
12/13/2006
-
GlaxoSmithKline And Massachusetts General Hospital Cancer Center Release: Lapatinib (Tykerb(R)) To Be Evaluated In Early Stage Disease In Adjuvant Breast Cancer Settings Internationally
12/13/2006
-
Reliant Pharmaceuticals, Inc. Submits New Data To FDA Supporting Use Of Omacor(R) (Omega-3-Acid Ethyl Esters) With A Statin To Reduce High Triglycerides
12/13/2006
-
BioMimetic Therapeutics, Inc. Announces Positive Results Using GEM OS1™ Bone Graft In Foot/Ankle Fusions
12/13/2006
-
Alexza Pharmaceuticals, Inc. Completes Enrollment In AZ-001 Phase IIb Clinical Trial In Patients With Migraine Headaches
12/13/2006
-
Keryx Biopharmaceuticals Commences Phase II, Multi-Center Study Of KRX-0401 For The Treatment Of Rare Sarcomas
12/13/2006
-
Millennium Pharmaceuticals, Inc. (Cambridge, Massachusetts) Release: VELCADE(R) (bortezomib) For Injection Incorporated Into NCCN(R) Clinical Practice Guidelines For Newly Diagnosed Multiple Myeloma
12/13/2006
-
Athenagen Inc. Initiates Phase II Clinical Trial In Alzheimer's Disease
12/13/2006
-
Vertex Pharmaceuticals Incorporated Announces Results Of First Interim Safety And Protease Inhibitor Telaprevir (VX-950)
12/13/2006
-
MicroIslet Inc. Holds Positive Pre-IND Meeting With FDA
12/13/2006
-
Crucell N.V. Announces Start Of Rabies Antibody Product Clinical Trial
12/13/2006
-
Active Biotech AB's Novel Cancer Treatment ANYARA Shows Pharmacological Proof Of Concept After Successful Phase I Studies
12/13/2006
-
Trigen Holdings AG Initiates Clinical Development With A Novel Therapeutic Protein, targeting Thrombosis And The Progression Of Atherosclerosis
12/13/2006
-
Cyclacel Pharmaceuticals, Inc. Submits IND Of CYC116 An Aurora Kinase And VEGRF2 Inhibitor To Treat Cancer
12/13/2006